Rabi Tawil, MD

Printer-friendly versionPrinter-friendly version

Rabi Tawil, MD, FAAN. Dr. Tawil completed his medical training at the American University of Beirut Faculty of Medicine in Beirut, Lebanon and his Neurology residency and Neuromuscular fellowship training at the University of Rochester, in Rochester, New York. He is currently professor of Neurology, co-Director of the MDA clinic and director of the Fields Center for FSHD and Neuromuscular Research.

Dr. Tawil's research spans all the muscle channel disorders especially the periodic paralyses.  His early work led to the clinical recognition and discovery of the genetic cause of the Andersen-Tawil Syndrome (ATS), the description of acetazolamide responsive sodium channel myotonia and the conduct of the first controlled, large scale, clinical trial in the periodic paralyses.

He is currently co-investigator with Dr. Robert C. Griggs on the HYP HOP trial, and consultant on the ongoing ATS study as part of the rare diseases network grant. He has served as a medical advisor to the Periodic Paralysis Association for a number of years.

Dr. Tawil's research interests also include the muscular dystrophies where he is a recognized expert on Facioscapulohumeral muscular dystrophy (FSHD) and served for a number of years on the FSH Society's medical advisory board. He is an elected member of the American Neurological Association and Fellow of the American Academy of Neurology. As a clinician-researcher, Dr. Tawil also provides care to patients with various neuromuscular disorders.